This complex inhibits the proliferation and promotes the differentiation of lung tumor cells via inhibiting activating protein-2 (AP-2), which result in re-sensitization of EGFR-TKIs resistant lung cancer cells [47]. Here, TFAP2A is linked to lung carcinoma.